I think—and I touched on it in the presentation—just by lengthening out the patent process for non-generic drugs it's going to potentially cost employers, workers, unions, and our provincial government between $29 million to $56 million a year starting in 2023. That's going to have a major negative impact on the ability of benefit plans and the ability of the provincial government to do other programs, if they're going to have to absorb those costs.
